Little Green Pharma Ltd (ASX: LGP)
Health Care · Pharmaceuticals · AU
AU$0.07
-4.00% today · -37.4% 1Y
Little Green Pharma Ltd (ASX: LGP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $42.26M and employs 94 people.
Over the last twelve months the share price has lost 37.4%, trading between 0.06 and 0.15.
Tweenvest scores Little Green Pharma Ltd across four factors: value 84/100, dividend 90/100. Its strongest factor is dividend.
LGP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.26M
- Revenue (TTM)
- $49.50M
- P/E
- 2.84
- EPS
- —
- Dividend yield
- 20.83%
- Beta (5Y)
- 0.33
- 52-week high
- AU$0.15
- 52-week low
- AU$0.06
- Avg volume (3M)
- —
- Shares outstanding
- 827.98M
- Employees
- 94
- Next earnings
- —
About Little Green Pharma Ltd
Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products. Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.
- ISIN
- AU0000074924
- Founded
- 2016
- Listed since
- Feb 19, 2020
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.16 | +0.12% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | 0.00% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.27 | -0.12% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.70 | -0.03% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.52 | -0.99% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.